Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Pharmaceuticals topic
No spam. Unsubscribe anytime.
Committee approves bill capping out-of-pocket cost for epinephrine at $100 per year
Summary
House Bill 236 would limit out-of-pocket costs for life-saving epinephrine auto-injectors to no more than $100 in a calendar year; the committee passed the bill unanimously.
House Bill 236, which would cap the out-of-pocket cost for epinephrine at $100 per calendar year, passed unanimously in committee and was reported favorably with an expression that it should pass on the House floor.
Representative Adam Moore, sponsor of the bill, told the committee the measure "limits the out of pocket cost for someone who needs life saving epinephrine to no more than a hundred dollars in a calendar year." Committee members expressed support; one member who said they personally use epinephrine described the cost burden and urged passage, noting the low manufacturing cost compared with retail prices and the life-or-death stakes when patients cannot replace expired doses.
Representative Gordon Frazier moved the bill and Representative McPherson seconded; the committee roll call recorded unanimous support and the chair announced the bill passed. The transcript excerpt does not include the bills full statutory text or a fiscal analysis in the committee record provided.
